Skip to main content

Wearable Healthcare Devices Market is Anticipated to Reach US $30.1 billion by 2026 – Exclusive Report by MarketsandMarkets™

Increasing Penetration of Smartphones and the Growing number of Smartphone-based Healthcare Devices

Chicago, Oct. 27, 2022 (GLOBE NEWSWIRE) — According to the new market research report Wearable Healthcare Devices Market by Product(Trackers, Smartwatch), Type(Diagnostic(BP, Glucose, ECG), Therapeutic(Pain, Insulin)), Grade(Consumer, Clinical), Channel(Pharmacies, E-commerce), Application(Fitness, RPM), & Region – Global Forecast to 2026″, the global wearable healthcare devices market is projected to reach USD 30.1 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 13.2%.

Browse in-depth TOC on “Wearable Healthcare Devices Market
223 – Tables
43 – Figures
250 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973

Scope of the Report:

Report Coverage Details
Market Size USD 30.1 billion by 2026
CAGR 13.2%
Historical Data 2019-2026
Base Year 2020
Forecast Period 2021-2026
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Product, By Device Type, By Grade Type, By Distribution Channel, By Application,  By Region
Geographies Covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Key Companies Profiled/Vendors Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), GE Healthcare (US), Fitbit Inc. (US), Abbott Laboratories (US), OMRON Corporation (Japan), Garmin Ltd. (US), Dexcom Inc. (US), Masimo Corporation (US), Medtronic PLC (Ireland), BioTelemetry Inc. (US), Preventice Solutions Inc. (US), iRhythm Technologies Inc. (US), Contec Medical Systems Co. Ltd. (China), MediBioSense Ltd. (UK), VitalConnect (US), Cyrcadia Health Inc. (US), Ten3T Healthcare (India), Verily Life Sciences (US), MinttiHealth (China), Bio-Beat (Israel), Biotricity Inc. (US), iHealth Lab Inc. (US), Vivalink (US), Gentag (US).
Key Market Opportunities Increasing adoption of artificial intelligence and 5G
Key Market Drivers Increasing awareness of fitness, lifestyle, and home healthcare

Increasing awareness of fitness, lifestyle, and home healthcare, development of technologically advanced products and growing geriatric population and subsequent increase in the incidence of chronic diseases are the major factors driving the wearable healthcare devices market’s growth.

Based on products, the wearable healthcare devices market is segmented into trackers, smartwatches, patches and smart clothing. In 2020, the trackers segment accounted for the largest share of the wearable healthcare devices market, mainly due to Growing geriatric population and subsequent increase in the incidence of chronic diseases and growing investments, funds, and grants.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=81753973

Based on device type, the wearable healthcare devices market is segmented into diagnostic and monitoring devices (vital sign monitoring devices (multiparameter tracker, ECGheart rate monitors, blood pressure monitors, pulse oximeter), glucose monitoring devices, sleep monitoring devices (wrist actigraphs, polysomnography devices), fetal monitoring devices, neuromonitoring devices and other diagnostic and monitoring devices) and therapeutic devices (pain management devices, rehabilitation devices, respiratory therapy devices and insulin pumps). In 2020, the diagnostic and monitoring devices segment accounted for the largest share of the wearable healthcare devices market. The large share of this segment can mainly be attributed to the robust penetration of 3G and 4G networks for uninterrupted healthcare services and growing preference for wireless connectivity among healthcare providers.

Based on grade type, the wearable healthcare devices market has been segmented into consumer grade wearable healthcare devices and clinical grade healthcare devices. In 2020, the consumer grade healthcare devices segment accounted for the largest share of the wearable healthcare devices market, mainly due to the increasing penetration of smartphones and the growing number of smartphone-based healthcare devices.

Based on distribution channel, the wearable healthcare devices market has been segmented into pharmacies, online channel and hypermarkets. In 2020, the pharmacies segment accounted for the largest share of the wearable healthcare devices market, mainly due to the growing preference for wireless connectivity among healthcare providers and growing investments, funds, and grants.

Based on application, the wearable healthcare devices market has been segmented into general health and fitness, remote patient monitoring and home healthcare. In 2020, the general health and fitness segment accounted for the largest share of the wearable healthcare devices market, mainly due to the increasing awareness of fitness, lifestyle, and home healthcare and growing geriatric population and subsequent increase in the incidence of chronic diseases.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=81753973

Geographical Growth Scenario:

The global wearable healthcare devices market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for wearable healthcare devices market in 2020. The large share of North America in this market can be attributed to the robust penetration of 3G and 4G networks for uninterrupted healthcare services and growing investments, funds, and grants.

Key Players:

The major players operating in this market are Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), GE Healthcare (US), Fitbit Inc. (US), Abbott Laboratories (US), OMRON Corporation (Japan), Garmin Ltd. (US), Dexcom Inc. (US), Masimo Corporation (US), Medtronic PLC (Ireland), BioTelemetry Inc. (US), Preventice Solutions Inc. (US), iRhythm Technologies Inc. (US), Contec Medical Systems Co. Ltd. (China), MediBioSense Ltd. (UK), VitalConnect (US), Cyrcadia Health Inc. (US), Ten3T Healthcare (India), Verily Life Sciences (US), MinttiHealth (China), Bio-Beat (Israel), Biotricity Inc. (US), iHealth Lab Inc. (US), Vivalink (US), Gentag (US).

Browse Adjacent MarketsMedical Devices Market Research Reports & Consulting

Browse Related Reports:

Home Healthcare Market

Medical Device Connectivity Market

Medical Equipment Maintenance Market

European Medical Equipment Maintenance Market

ENT Devices Market

CONTACT: About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.